• Profile
Close

A panel of miRNAs as prognostic markers for African-American patients with triple negative breast cancer

BMC Cancer Jul 30, 2021

Turkistani S, Sugita BM, Fadda P, et al. - Researchers sought to determine the global expression profile of microRNAs (miRNAs), their influence on cellular signaling pathways, as well as their link with poor prognostic parameters among African-American (AA) patients suffering from triple negative breast cancer (TNBC). They found that a panel of eight, 23 and 27 miRNAs were related to tumor size, lymph node (LN), and recurrence (REC) status, respectively. A robust discriminatory power based on tumor size (AUC = 0.917), LN (AUC = 0.945) and REC (AUC = 0.981) status was demonstrated by integrated ROC analysis of two (miR-2117, and miR-378c), seven (let-7f-5p, miR-1255b-5p, miR-1268b, miR-200c-3p, miR-520d, miR-527, and miR-518a-5p), and three (miR-1200, miR-1249-3p, and miR-1271-3p) miRNAs, respectively. Overall, miRNA deregulated expression was revealed as a relevant biological factor, and a poor prognosis in TNBC of AA patients can be seen in relation to miRNA deregulated expression as it confers to their TNBC cells aggressive phenotypes that are reflected in the clinical features assessed in this study.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay